People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

25.28USD
2 Jul 2015
Change (% chg)

$-0.03 (-0.12%)
Prev Close
$25.31
Open
$25.34
Day's High
$25.53
Day's Low
$24.77
Volume
40,999
Avg. Vol
126,953
52-wk High
$30.49
52-wk Low
$15.37

Search Stocks

Strobeck, Matthew 

Dr. Matthew W. Strobeck, Ph.D., is an Independent Director of Accelerate Diagnostics Inc., since July 7, 2012. He has served as a Director of the Company since July 7, 2012. Dr. Strobeck is currently the Managing Partner of Birchview Capital. Dr. Strobeck was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from the Harvard University/MIT Health Sciences Technology Program, and a S.M. from the MIT Sloan School of Management.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Patience

--

Lawrence Mehren

893,783

Steve Reichling

370,228

Ron Price

--

Pete Bantock

368,553

Mark Miller

--
As Of  30 Dec 2014
Search Stocks